COLO320 cells: siCDX2 vs. non-targeting control

ABSTRACT: Somatic DNA alteration underlies tumor development and progression, and gives rise to tumors with diverse genetic contexts. Here, we identify in a collection of 29 colorectal cancer cell lines and 226 primary colorectal tumors recurrent amplification of chromosome 13, an alteration highly restricted to colorectal-derived cancers. A minimal region of amplification on 13q12.2 pinpoints caudal type homeobox transcription factor CDX2, a master regulator of anterior-posterior patterning, midgut development, and intestinal epithelial cell differentiation and maintenance. In contrast to its described role as a colorectal tumor suppressor, we show that in the context of genomic amplification, CDX2 is required for proliferation and anchorage-independent growth of colorectal cancer cells. By genome-

ORGANISM(S): Homo sapiens

SUBMITTER: Keyan Salari 

PROVIDER: E-GEOD-30181 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress